2023 IAB Companies and Representatives
Agilent Technologies Inc. is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Representatives: Lingfeng Wu, Dan Cuthbertson
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method reducing background signal and increasing sensitivity and dynamic range compared with standard approaches. The NULISAseq Inflammation Panel contains 200+ important markers and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands-on time from sample to data.
Representatives: Anna Berdine, Bingqing Zhang
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease.
Representatives: Sara Ahadi, Balazs Szoke
Asia’s leading proteomics company with proteomics platform comprised of quantitative proteomics analysis capabilities and world-class bioinformatics capabilities. Notably, Bertis successfully commercialized breast cancer early Dx diagnostics service – Mastocheck – in Asia after receing K-FDA approval in 2019. And looking to expand further pipelines, such as pancreatic cancer and ovarian cancer.
Representatives: Dr. Sangtae Kim, Dr. Unbeom Kang
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that can dramatically improve human health. We enable life science researchers and drug hunters to look at the proteome from every angle with our versatile portfolio of proprietary next-generation proteomics services, software, and kits. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Biognosys’ unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.
Representatives: Kristina Beeler, Yuehan Feng
Bruker provides innovative mass spectrometry systems for proteomics that overcome long-standing limitations in speed, sensitivity and robustness. We offer a complete range of proteomics solutions to enhance analytical depth and throughput and to minimize maintenance and downtime.
Representatives: Gary Kruppa, Pierre-Olivier Schmit
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the manufacturer of stable isotopes (e.g.,13C, D, 15N) and their compounds for an array of qualitative/quantitative research applications ranging from analytical chemistry to modern diagnostics. Proteomic products include peptide synthesis and protein expression starting materials, SILAC and SILAM reagents/kits, QC and quantitation kits, chemical tagging reagents, and enzymatic labeling reagents. CIL also offers an array of standards and mixes/kits for use in other MS ‘omics research (e.g., metabolomics, glycomics).
Representatives: Joel Louette, Andrew Percy
EVOSEP aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Representatives: Michael Andersen, Nicolai Bache
Illumina is an applied genomics technology company making genomics useful for all. We are tirelessly working to create the leading-edge technology that enables clinicians and researchers to not only understand the genome but also fully tap its power. Discoveries that were unimaginable just a few years ago are becoming routine, and we’re just getting started.
Representatives: Dalia Daujotyte, Fiona Kaper
IonOpticks is revolutionising chromatography with robust and highly reproducible nanoflow columns that are leading the market in spray stability and depth of sample characterisation. Coupling integrated packed emitter tip technology with our nanoZero fittings, IonOpticks achieves true zero dead volume, providing a unique ability to enhance the sensitivity of protein sample analysis and identify more proteins per run than ever before.
Representatives: Jarrod Sandow, Michael Sinden
Nautilus Biotechnology - Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.
Representatives: Sheri Wilcox, Jamie Rose Kuhar
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume, we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Representatives: Marijana Rucevic, Sarantis Chlamydas
Pelago Bioscience was founded in 2013 with the aim to maximize the awareness and use of our patented Cellular Thermal Shift Assay (CETSA®). Using CETSA we deliver in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. Our scientific team are the experts in both targeted (Classics & HT) and unbiased proteomics CETSA applications (CETSA MS/Thermal Proteome Profiling).
Representatives: Johan Lengqvist, Stina Lundgren
ProtiFi, LLC provides innovative solutions for omics analyses from sample preparation trough to data analysis and is a spin out of Cold Spring Harbor Laboratory. The S-Trap, our sample extraction, concentration and cleaning system, has revolutionized our ability to obtain MS ready samples in record time regardless of sample or skill level. Tryp-N, “N-terminal trypsin,” gives complementary data to increase sequence coverage and certainty of identification. Finally, Simplifi makes it easy and simple to go from huge omics datasets to meaning and understanding of biology.
Representatives: John Wilson, Joanna Kirkpatrick
Quantum-Si Incorporated - From our founding in 2013, we’ve been focused on democratizing protein sequencing so that every day scientists can generate deeper insights faster. By solving complex biological, chemical, and mechanical problems, we are removing barriers to scientific discovery and bringing protein sequencing to every bench.
Representatives: Brian Reed, Katherine Johnson
SCIEX solutions for biomarker & omics research enable scientists to push the limits in discovery proteomics, targeted peptide quantitation, lipidomics, metabolomics, protein characterization, and tissue imaging.
Representatives: Katherine Tran, Patrick Pribil
Seer develops innovative solutions that act as a gateway to the proteome. Our products are designed to accelerate the pace of proteomics by removing the technological barriers that stand between you and the proteomics you want to do. The Proteograph platform enables unbiased, deep, rapid, large-scale proteomics studies – the kind needed to advance our understanding of biology, health, and disease. Our goal is to empower the scientific community with tools for exceptional proteomics outcomes.
Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. KREX was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.
Representatives: Jonathan Blackburn, Katy McGirr
SomaLogic seeks to deliver meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from the precise, proprietary, and personalized measurement of health-related changes in an individual’s proteins over time.
Representatives: Sean Lynch, DeAunne Denmark
Thermo Scientific is the leading source of innovative, comprehensive workflow solutions to address the most challenging aspects of proteomics research.
Representatives: Kay Opperman, Thomas Moehring
From biomarker discovery and translational research through to clinical diagnostic solutions, at Waters, we strive to improve human health by partnering with the biomedical community to help make breakthrough scientific discoveries and translate them into healthcare solutions.
Representatives: David Heywood, Roy Martin